Cargando…

Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications

The development of medicine is based not only on the introduction of new methods of treatment, but also on the use of increasingly effective drugs, including antithrombotic drugs. Drugs that inhibit the activity of platelets (antiplatelet and anti-aggregating drugs) and pharmaceuticals that inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wójcik, Sylwia, Mocny-Pachońska, Katarzyna, Bisch-Wójcik, Sophie, Balicz, Agnieszka, Morawiec, Tadeusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737598/
https://www.ncbi.nlm.nih.gov/pubmed/36498241
http://dx.doi.org/10.3390/ijerph192316151
_version_ 1784847330477867008
author Wójcik, Sylwia
Mocny-Pachońska, Katarzyna
Bisch-Wójcik, Sophie
Balicz, Agnieszka
Morawiec, Tadeusz
author_facet Wójcik, Sylwia
Mocny-Pachońska, Katarzyna
Bisch-Wójcik, Sophie
Balicz, Agnieszka
Morawiec, Tadeusz
author_sort Wójcik, Sylwia
collection PubMed
description The development of medicine is based not only on the introduction of new methods of treatment, but also on the use of increasingly effective drugs, including antithrombotic drugs. Drugs that inhibit the activity of platelets (antiplatelet and anti-aggregating drugs) and pharmaceuticals that inhibit the activity of plasma coagulation factors (anticoagulants) are used in antithrombotic therapy. In our daily practice we encounter patients who take chronic antiplatelet or anticoagulant drugs. However, more and more often we are dealing with patients who are treated with two antiplatelet drugs, an antiplatelet and an anticoagulant or even undergoing triple antithrombotic therapy. When preparing the patient for invasive craniofacial procedures, it should be assessed whether the temporary discontinuation of antithrombotic treatment due to the fear of excessive perioperative bleeding is justified and will not result in life-threatening thromboembolic complications. The authors discuss in detail the medications used in modern antithrombotic treatment and present a perioperative management procedure with a patient who takes l4 z of these medications chronically.
format Online
Article
Text
id pubmed-9737598
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97375982022-12-11 Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications Wójcik, Sylwia Mocny-Pachońska, Katarzyna Bisch-Wójcik, Sophie Balicz, Agnieszka Morawiec, Tadeusz Int J Environ Res Public Health Review The development of medicine is based not only on the introduction of new methods of treatment, but also on the use of increasingly effective drugs, including antithrombotic drugs. Drugs that inhibit the activity of platelets (antiplatelet and anti-aggregating drugs) and pharmaceuticals that inhibit the activity of plasma coagulation factors (anticoagulants) are used in antithrombotic therapy. In our daily practice we encounter patients who take chronic antiplatelet or anticoagulant drugs. However, more and more often we are dealing with patients who are treated with two antiplatelet drugs, an antiplatelet and an anticoagulant or even undergoing triple antithrombotic therapy. When preparing the patient for invasive craniofacial procedures, it should be assessed whether the temporary discontinuation of antithrombotic treatment due to the fear of excessive perioperative bleeding is justified and will not result in life-threatening thromboembolic complications. The authors discuss in detail the medications used in modern antithrombotic treatment and present a perioperative management procedure with a patient who takes l4 z of these medications chronically. MDPI 2022-12-02 /pmc/articles/PMC9737598/ /pubmed/36498241 http://dx.doi.org/10.3390/ijerph192316151 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Wójcik, Sylwia
Mocny-Pachońska, Katarzyna
Bisch-Wójcik, Sophie
Balicz, Agnieszka
Morawiec, Tadeusz
Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications
title Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications
title_full Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications
title_fullStr Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications
title_full_unstemmed Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications
title_short Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications
title_sort perioperative management of dental surgery patients chronically taking antithrombotic medications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737598/
https://www.ncbi.nlm.nih.gov/pubmed/36498241
http://dx.doi.org/10.3390/ijerph192316151
work_keys_str_mv AT wojciksylwia perioperativemanagementofdentalsurgerypatientschronicallytakingantithromboticmedications
AT mocnypachonskakatarzyna perioperativemanagementofdentalsurgerypatientschronicallytakingantithromboticmedications
AT bischwojciksophie perioperativemanagementofdentalsurgerypatientschronicallytakingantithromboticmedications
AT baliczagnieszka perioperativemanagementofdentalsurgerypatientschronicallytakingantithromboticmedications
AT morawiectadeusz perioperativemanagementofdentalsurgerypatientschronicallytakingantithromboticmedications